SYSMEX CORPORATION

Investor Relations

HOME > Investor Relations > Sysmex in Brief

Sysmex in Brief

  • About us
  • Strengths
  • Strategies
  • The future
  • Performance
  • Dividends

1. As we evolve and move to a new phase of growth, we are promoting three core strategies.

As we evolve and move to a new phase of growth, we are promoting three core strategies.

Sysmex has defined three core strategies for achieving the objectives of its long-term vision. Based on these strategies, we aim to sustain ongoing growth and increased profitability.

Long-Term Vision: A Unique & Global Healthcare Testing Company

As a company that is both unique and global, we will provide customers with solutions that showcase our advanced technologies and unique strengths, securing our position as a leader in the niche of healthcare testing.

Three Core Growth-Oriented Strategies

Leading Hematology

・Secure an undisputed leadership position
・As an industry frontrunner, provide products that offer new value and high levels of usability

Leading in Emerging Markets

・Establish uniqueness as a comprehensive IVD supplier
・Introduce products and services that meet emerging market needs, and reinforce sales and support networks
・Lead diagnostics development in emerging markets

Innovating Life Science

・Create unique testing technologies in the area of molecular diagnostics, centering on cancer
・Create new value, such as integrating personalized medicine with treatment and diagnosis


The worldwide market for testing is growing.

Sysmex Corporation

Copyright© SYSMEX CORPORATION, All Rights Reserved.